Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120

scientific article published on June 1, 1992

Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1172/JCI115802
P953full work available at URLhttps://europepmc.org/articles/PMC295896
https://europepmc.org/articles/PMC295896?pdf=render
P932PMC publication ID295896
P698PubMed publication ID1376330
P5875ResearchGate publication ID21780043

P50authorNancy HaigwoodQ55205394
P2093author name stringA. Takeda
F. A. Ennis
D. D. Ho
C. Debouck
J. E. Robinson
P2860cites workInfection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodiesQ27485071
Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSQ28262859
Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strainQ33880904
Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDSQ34250436
Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitroQ36793253
Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R.Q36793493
Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibodyQ40062738
Identification of Conserved and Variant Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) gp120 by Human Monoclonal Antibodies Produced by EBV-Transformed Cell LinesQ41736501
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entryQ42126903
Antibody-dependent enhancement of human immunodeficiency virus type 1 infectionQ43684895
HIV infection of monocytic cells: rôle of antibody-mediated virus binding to Fc-gamma receptorsQ44550044
Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodiesQ44683552
Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency SyndromeQ45807119
Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).Q45839109
Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitroQ45845087
The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cellsQ46073217
A novel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter wells coated with concanavalin AQ68536789
Development of a confirmatory enzyme-linked immunosorbent assay for HIV-1 antibodiesQ69506281
Second conserved domain of gp120 is important for HIV infectivity and antibody neutralizationQ69819599
Antibody-dependent enhancement of HIV infectionQ69918764
Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assayQ70074596
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectantibodyQ79460
monoclonal antibodyQ422248
P304page(s)1952-1957
P577publication date1992-06-01
P1433published inJournal of Clinical InvestigationQ3186904
P1476titleDistinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120
P478volume89

Reverse relations

cites work (P2860)
Q35876233A novel antibody-dependent cellular cytotoxicity epitope in gp120 is identified by two monoclonal antibodies isolated from a long-term survivor of human immunodeficiency virus type 1 infection
Q34009510A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection
Q27485451Antibody-Dependent Enhancement of Hepatitis C Virus Infection
Q36421569Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).
Q24538755Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients
Q45281480Detection of IgA-binding sites on human immunodeficiency virus type-1 envelope glycoproteins, Gp120 and Gp41.
Q36549107Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope
Q35890076Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody.
Q45375987Evaluation of the immune response and protective effects of rhesus macaques vaccinated with biodegradable nanoparticles carrying gp120 of human immunodeficiency virus
Q38524329HIV-1 gp120: a novel viral B cell superantigen
Q36649929Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo
Q28236244Manipulation of cell surface macromolecules by flaviviruses
Q33783763Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes
Q24634681Pathogenesis of human immunodeficiency virus infection

Search more.